Search Results 291-300 of 397 for ������������������KaKaoTalk:PC53������������������ ������ ������
Part 2 is a 12-week treatment, randomized, placebo-controlled, double-blind, safety and exploratory effectiveness study. Part 2 will be initiated only after the ...
Learn more about this specialized laser surgery that's a minimally invasive option for treating an enlarged prostate.
About this study. The study is a multicenter, open label Phase I/II trial. 1. Establish the MTD of fractionated doses of Lintuzumab-Ac225 in combination ...
The study is being conducted to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of 3HP-2827 in the treatment of unresectable ...
Flu cases are dropping but a new COVID-19 variant. XBB.1.5 is on the rise. Hear from a Mayo Clinic infectious diseases expert about the virus.
While research and clinical observations on the new strain are underway, it is not yet known what impact, if any, omicron will have on the immune response, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...
Dr. Poland gives an update on progress towards a vaccine for COVID-19, discusses therapies for treating the virus and shares research on how effective face ...
Short-Course, Hypofractionated Proton Beam Therapy Incorporating 18F-DOPA PET–MRI for Older Patients With Newly Diagnosed Glioblastoma: A Prospective Phase 2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.